https://www.selleckchem.com/pr....oducts/PHA-793887.ht
43 [0.27, 0.73]). Odds for cardiovascular morbidity was not significantly lower in the etomidate cohort (0.86 [0.66, 1.12]) than the propofol cohort. Infectious morbidity was 1.77 times higher in the etomidate cohort (1.77 [1.35, 2.31]). The odds for death per 0.1 mg/kg of etomidate was estimated as 1.36 times higher (1.36 [95% CI 1.23, 1.49]). Etomidate is not a wise choice as the hypnotic drug on the day of starting mechanical ventilation, as it is associated with the increased all-cause mortality in a dose-dependent manner, while